GlassScriptPhysician profile
Hannah Winningham
NPI 1952702714
$1,093.11
in general payments reported to CMS, 2019-2025
11 companies · $129 in 2025
The $129 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $258 · 2023: $286 · 2024: $251 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $360.38 | 2021-2024 | Jornay Pm |
| Corium, LLC | $316.75 | 2021-2025 | Azstarys |
| Glaxosmithkline, LLC. | $211.14 | 2021-2025 | Bexsero, Pediarix, Infanrix |
| Pfizer INC. | $47.54 | 2024 | |
| Sobi, INC | $30.59 | 2021-2022 | |
| Sanofi Pasteur INC. | $30.33 | 2023-2024 | |
| Neuraxis, INC. | $28.33 | 2024 | |
| Tris Pharma INC | $20.94 | 2025 | Onyda Xr |
| Verrica Pharmaceuticals INC. | $19.55 | 2025 | Ycanth |
| Merck Sharp & Dohme LLC | $14.42 | 2025 | Enflonsia, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $13.14 | 2024 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Winningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.